The present results contribute to the in vivo characterization of the behavioral impact of Akt signaling pathway dysfunction and support the conceptualization of qualitative and quantitative variations of neural circuit disruptions underpinning phenotypic differences that are relevant to several mental disorders. This evidence concerns the gene AKT1 and psychiatric disorder.